Seeking Alpha

Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by...

Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by $2M. Reaffirms FY11 Revenue guidance of $520M and PAT of $110M (excl. payments to Lupin). Shares +0.5% AH. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs